Metrorrhagia juvenilis and hormonal therapy
Shqipe Fetiu (KO), Myrvete Pacarada (KO), Florije Belegu (KO), Brikena Daci (KO)
[Fetiu] 1. Department of Gynecology, University Clinical Center of Kosova; Medical Faculty, University of Prishtina, Prishtine, Kosovo., [Pacarada] 1. Department of Gynecology, University Clinical Center of Kosova; Medical Faculty, University of Prishtina, Prishtine, Kosovo., [Belegu] 1. Department of Gynecology, University Clinical Center of Kosova; Medical Faculty, University of Prishtina, Prishtine, Kosovo., [Daci] 1. Department of Gynecology, University Clinical Center of Kosova; Medical Faculty, University of Prishtina, Prishtine, Kosovo.
We report study conducted on 19 young patients based one the use of a hormonal treatment for three months , monitoring of the evolution of their main juvenils symptoms; irritability, quality of sleep, quality of life, fatigue, anemia and metrorhagia .The mean value of menarche for juvenile metrrorrhagia is 11,5 years . 18 of the patients were hospitalized and 3 necessitated blood transfusion. With ultrasonografy is followed endometrial thickness and have appointed therapy. Temination of this condition was achieved with gestagen therapy , when bleeding have started two weeks ago . Gestagen therapy (Duphaston 10 mg ) continued two weeks (15 cases). When bleedindg have started more two weeks , we have started treatment with Estrofen 2 mg -3x2 (two days) then -3x1 (two days) then 2x1 (two days). Before that therapy continued 1x1, but in 12-13 days of started therapy we have added gestagen therapy 2x1 ,two weeks. After 3 months of estrogen therapy and gestagen therapy , we measured the evolution of juvenile symtoms in frequency and intensity.There was no significant discrepancy between the gestagen and estrogen therapy group for all studied parameters. Key word: gestagen therapy,estrogen therapy,metrorrhagia juvenilis